Connect with us

Health

Adjuvant chemotherapy can improve overall survival in patients with high-risk, low-grade glioma – News-Medical.net

A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade g…

Published

on

Reviewed by Emily Henderson, B.Sc.Sep 1 2020
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.
The study results, published in a recent issue of the Journal of Clinical Oncology, sought to d…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending